Rodman David Malcom bought MLYS
March 12, 2026 · Form 4 insider transaction
Rodman David Malcom bought 6,348 shares of Mineralys Therapeutics, Inc. at $1.08 per share, a transaction worth $6.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,348
Price
$1.08
Total value
$6.9K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after88,837
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.